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PENGGUNAAN UBAT KOMPLEMENTARI  DAN ALTERNATIF DALAM 
KALANGAN PESAKIT KANSER DI PULAU PINANG, MALAYSIA: PENILAIAN 
KUALITATIF DAN KUANTITATIF  TERHADAP KEPERCAYAAN 
KESIHATAN, PENDEDAHAN RAWATAN DAN KESIHATAN BERKAITAN 
KUALITI HIDUP 
 
ABSTRAK 
 
Penggunaan perubatan alternatif dan komplementari (CAM) adalah meluas untuk 
penjagaan kesihatan dan pengurusan gejala-gejala penyakit. Di Malaysia, terdapat bukti 
bahawa pelbagai CAM digunakan oleh pesakit dengan kanser. Pesakit kanser cenderung 
untuk menggunakan CAM dalam usaha untuk mengurangkan berulangnya kanser dan 
mengurangkan kesan-kesan sampingan akibat terapi konvensional. Kajian ini bermatlamat 
umtuk  menyediakan suatu penilaian yang komprehensif mengenai kepercayaan kesihatan, 
pendedahan rawatan dan kesihatan berkaitan kualiti hidup bagi pesakit kanser dalam 
konteks perubatan alternatif dan komplementari (CAM). Suatu pendekatan metodologi 
gabungan diadaptasi dengan menggunakan kedua-dua kaedah kualitatif dan kuantitatif. 
Analisis kandungan bertema mengenal pasti tiga tema utama: kepercayaan pesakit terhadap 
kanser dan rawatannya, persepsi pesakit terhadap penggunaan CAM bagi merawat kanser 
dan pendedahan tentang penggunaan  CAM kepada ahli penjagaan kesihatan. Sejumlah 20 
orang pesakit ditemu bual;  12 orang telah menggunakan  CAM,  sementara itu, hanya  4 
orang mengetahuinya daripada  doktor.  Keberkesanan CAM yang agak lambat dan kos 
dinyatakan sebagai penghalang terhadap  penggunaan CAM.  Pesakit  bersetuju bahawa  
pendedahan tentang CAM adalah penting untuk mengelak sebarang interaksi dengan ubat 
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konvensional. Tanggapan bahawa kurangnya pengetahuan dan minat dalam kalangan 
doktor terhadap CAM serta kebimbangan terhadap penamatan terapi oleh doktor semasa 
pendedahan CAM menjadi alasan mengapa  CAM tidak didedahkan.    
Keputusan kuantitatif menunjukkan bahawa daripada 393 orang pesakit, 184 (46.8%) 
dilaporkan  menggunakan CAM.  Dalam kalangan semua data demografi dan penyakit, 
penggunaan CAM secara signifikan dikaitkan dengan tahap pendidikan   (p=0.001), status 
pekerjaan (p=0.02), gender (p=0.021) dan pendapatan bulanan isi rumah (p<0.001). 
Penggunaan CAM yang paling biasa adalah terapi berasaskan biologi  (72.8%).  Seramai  
 
 
80 (43.5%) orang peserta tidak pasti jumlah yang mereka belanjakan untuk CAM setiap 
bulan.   Sementara itu, 139 (75.5%) orang peserta mengatakan bahawa kawan-kawan dan 
ahli keluarga merupakan sumber maklumat utama CAM.  Sikap pengguna CAM terhadap 
terapi  CAM secara signifikan berbeza daripada sikap mereka terhadap terapi konvensional 
(p<0.05).  Dilaporkan bahawa pengguna CAM lebih mempercayai keberkesanan terapi 
konvensional  daripada terapi CAM.  Kadar pendedahan  CAM adalah 43%,  namun 
demikian; hanya 62 (33.7%) kes yang doktor bertanyakan tentang penggunaan CAM 
kepada pesakit. Dapatan bagi  kajian kesihatan berkaitan kualiti hidup (HRQoL) 
menunjukkan bahawa  peserta perempuan (p=0.035) berbangsa Melayu (p=0.047)  yang 
benar-benar mengamalkan ajaran Islam  (p=0.011) didapati mempunyai skor Status 
Kesihatan Global (GHS) yang baik. Pesakit yang mempunyai insurans perubatan juga 
menunjukkan skor GHS yang baik  (p=0.021). Pesakit kanser pada tahap yang kritikal 
dilaporkan mempunyai skor min GHS yang rendah  (p<0.001). Dalam kalangan pengguna 
dan bukan pengguna CAM, skor GHS menunjukkan perbezaan yang signifikan (p=0.002).  
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Sebagai kesimpulan, kajian ini mengenal pasti bahawa CAM biasanya digunakan dalam 
kalangan pesakit kanser di Malaysia.  Penggunaan CAM yang pelbagai atau berbeza 
mendorong lebih banyak penyelidikan dijalankan berkaitan dengan keberkesanan terapi ini 
untuk rawatan kanser. Secara relatif, pendedahan tentang CAM adalah sesuatu yang baik, 
namun demikian perkara ini tidak dipraktikkan sebaiknya oleh para doktor. Hal ini 
memerlukan penyelidikan lanjut.  Kanser juga dilaporkan memberi kesan terhadap kualiti 
hidup pesakit, dari segi fungsi dan juga emosi.  Pengguna  CAM dilaporkan mempunyai 
skor kualiti hidup yang amat rendah dibandingkan dengan bukan pengguna CAM, yang 
memerlukan penyelidikan lanjut tentang kesan daripada CAM yang berpotensi memberi 
manfaat atau yang mungkin memudaratkan kualiti hidup pesakit.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxix 
 
 
 
USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINES AMONG 
CANCER PATIENTS IN PENANG, MALAYSIA: A QUALITATIVE AND 
QUANTITATIVE ASSESSMENT OF HEALTH BELIEFS, TREATMENT 
DISCLOSURE AND HEALTH RELATED QUALITY OF LIFE 
 
ABSTRACT 
 
The use of Complementary and Alternative Medicines (CAM) is widespread for general 
health maintenance and management of disease symptoms. In Malaysia, there is evidence 
that a variety of CAM is used by patients with cancer. Cancer patients tend to use CAM in 
an attempt to reduce cancer recurrence and to lessen the side effects due to conventional 
therapies. The study aimed to provide a comprehensive evaluation of health beliefs, 
treatment disclosure and health related quality of life of cancer patients in the context of 
CAM.  A mixed methodological approach using both qualitative and quantitative methods 
was adapted. The thematic content analysis identified three major themes: patients’ beliefs 
towards cancer and its treatment, patients’ perceptions toward the use of CAM for cancer 
treatment and the disclosure of CAM use to the health care providers. Twenty patients 
were interviewed, twelve of them reported to use CAM while only four disclosed it to the 
doctors. The slow progression of CAM effectiveness and cost were given as barrier to 
CAM use. Patients agreed that CAM disclosure is important to avoid any interaction with 
the conventional medicines. Perceived lack of physicians’ knowledge & interest in CAM, 
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fear of termination of therapy by the physicians upon CAM disclosure was given as 
reasons of CAM non disclosure.  
The quantitative results revealed that out of 393 patients, 184 (46.8%) reported to use 
CAM. Among all the demographic and disease variables, CAM usage was significantly 
associated with the level of education (p=0.001), employment status (p=0.021), female 
gender (p=0.021) and monthly household income (p<0.001). The most common CAM 
used was biologically based therapies (72.8%). Nearly half of the participants 80 (43.5%) 
were not sure of their monthly CAM expenditure. Friends and family members 139 
(75.5%) were the most common source of CAM information. CAM users’ attitudes toward 
CAM therapies differ significantly from their attitude towards conventional therapies 
(p<0.05). CAM users reported to believe in the effectiveness of conventional therapies 
more than CAM therapies. CAM disclosure rate was 43%, however; only in 62 (33.7%) 
cases doctors had specifically asked about patients’ CAM use. The HRQoL of the 
participants in general showed female gender (p=0.035), Malay ethnicity (p=0.047) and 
patients practicing Islam as their religion (p=0.011) were having better Global Health 
Status (GHS) scores. Patients having medical insurances also showed better GHS score 
(p=0.021). Patients at very advanced stages of cancer reported to have lower GHS mean 
scores (p<0.001). Among the CAM users and non users only the GHS scores shows 
significant difference (p=0.002).  
In conclusion the study identified that CAM use is common among Malaysian cancer 
patients. Different types of CAM were used by the patients which welcomes more research 
on effectiveness of these therapies for cancer. CAM disclosure was relatively better 
however doctors’ enquiry on patients’ CAM use was very low which requires further 
investigation. Cancer is reported to affect patients’ quality of life functionally and 
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emotionally. CAM users reported to have poor quality of life scores as compare to CAM 
non users which requires further investigation on potential beneficial or harmful effects of 
CAM on patients’ quality of life. 
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CHAPTER ONE: GENERAL INTRODUCTION 
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1.1 Background to research 
The use of Complementary and Alternative Medicines (CAM) is increasing in Malaysia 
among healthy individuals as well as among patients with chronic diseases including 
cancer (Hasan et al., 2009). This demands an investigation about the frequency and 
patterns of CAM use among cancer patients to assess its implications in cancer care. It is 
evident that beside other factors such as perception of the disease and fear of cancer 
treatment, a strong belief in traditional modes of healings is among the factors contributed 
in presentation of cancer at advanced stages among Malaysian cancer patients (Taib et al., 
2007). Similarly the psychological impact of cancer diagnosis contributes to problems such 
as depression and anxiety for patients and their care givers (Saniah & Zainal, 2010). As a 
consequence of these factors, cancer patients usually try different treatment options in a 
desperate search for a cure. Choosing CAM for cancer is a complex process. Due to the 
availability of a wide range of CAM the decision to use these therapies often puts patients 
and their care givers in a dilemma as they try to choose the best for their cancers. Figure 
1.1 summarizes the steps involved in the CAM decision making process. 
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Figure 1.1 Summary of CAM decision making process for cancer patients (Note: 
TDP-Treatment Decision making Process, CT-Conventional Therapies, CAM-
Complementary and Alternative Medicines) 
 
Patients’ decision to use CAM is highly individualized and involves multiple factors. 
Combining CAM therapies with conventional cancer treatments may have the potential to 
cause adverse effects (Boon et al., 2000). The slow progression of the effects of CAM may 
delay patients from seeking proven therapies for cancer. Communication between patients 
and health care providers may help patients to seek the right CAM at the right time. Due to 
these reasons it is crucial to investigate why and how people decide to use CAM for 
cancer. Studies that have attempted to evaluate patients’ decision making processes in 
CAM use show that the decision to use CAM does not only depend on demographic and 
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disease characteristics but is also due to the perceived effectiveness of CAM and 
conventional treatments and experiences within health care systems (Boon et al., 1999; 
Boon et al., 2003). Such investigations may benefit patients and their health care providers 
in designing programs to educate patients on the use of Evidence Based Medicines (EBM) 
for cancer and the importance of CAM use discussion with health care providers.  
The integration of CAM into the modern health care system is considered as an effective 
tool to provide a holistic approach to cancer care rather than merely focusing on a disease 
oriented approach (Ben-Arye et al., 2012). In the Malaysian context the concept of 
integrative medicine has emerged in the last two decades with an increasing recognition of 
the popularity of traditional medicines and the potential of combining them with evidence 
based medicinal CAM to offer supportive cancer care. Several integrative medicine units 
have been set up throughout the country to ensure patients receive proven therapies for 
cancer (Portal Rasmi Bahagian Perubatan Tradisional & Komplementari, 2011). However, 
the decision of patients to use CAM is still unexplored among Malaysian cancer patients. 
The current study aimed: 
i) To determine the prevalence and types of CAM used by cancer patients, their 
monthly expenditure and sources of information on CAM. 
ii)  To determine the beliefs of CAM users and non users towards the causes and 
curability of cancer. 
iii) To determine the beliefs of CAM users and non users towards the effectiveness 
of CAM and conventional therapies for cancer treatment. 
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iv) To determine the overall CAM disclosure rate to doctors, doctor’s 
investigations of their patients’ CAM use and patients’ reason of CAM non 
disclosure. 
v) To compare the Health Related Quality of Life (HRQoL) of cancer patients in 
the context of CAM. 
1.2 Justification of the study 
In the research area, few studies have attempted to evaluate CAM use among cancer 
patients in Malaysia, these studies are confined to certain types and stages of cancer among 
specific ethnic groups only (Lua, 2011; Shaharudin et al., 2011). These studies were unable 
to adequately identify the ethno-cultural differences which affect the decision to use CAM. 
Increased incidence of cancer among Malaysians, and presentation at advanced stages, 
demands an in-depth investigation to identify the key issues to understanding Malaysian 
cancer patients’ decision to use CAM. Malaysian literature is still lacking data on how 
cancer patients perceive the effectiveness of CAM over conventional medicines. Patient-
doctor communication on cancer treatment also affects patients’ treatment seeking 
behaviour. However, this issue is poorly explored in the Malaysian context. Issues related 
to monthly CAM expenditure would help to identify methods to offer some subsidies or 
medical coverage of CAM in the Malaysian health care system. Evaluation of Health 
Related Quality of Life (HRQoL) of cancer patients in general and to different types of 
CAM therapies specifically would help to provide better opportunities to improve the 
health policies on CAM.    
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1.3 Overview of the thesis 
Chapter 2 takes the form of a literature review and provides an overview of incidence of 
cancer in Malaysia and its impact on the Malaysian health care system. The role of CAM 
in the Malaysian health care system with specific reference to cancer is discussed in detail. 
The practice of CAM decision making processes and the factors associated with CAM use 
is provided in a later section of this chapter. CAM disclosure to health care providers and 
specifically to doctors is discussed. Lastly the chapter concludes by exploring issues 
related to CAM use and HRQoL of cancer patients. Chapter 3 elaborates on two different 
methodological approaches i.e. qualitative and quantitative methods, and how they have 
been adapted for this thesis. Chapter 4 presents the results from the qualitative phase of the 
research. This chapter presents cancer patients’ beliefs in relation to cancer and its 
treatment, CAM use CAM decision making process and decisions of patients regarding 
CAM disclosure to the doctors. 
Chapter 5 presents the results from the quantitative phase of the thesis. This chapter 
discusses the use of CAM among cancer patients, their beliefs towards the effectiveness of 
CAM and conventional medicines for cancer, and CAM disclosure to the doctors. Chapter 
6 aims to present the Health Related Quality of Life (HRQL) of cancer patients in the 
context of CAM.  Chapter 7 draws the thesis towards conclusion, reviewing the 
implications of the study findings, limitations of the approach used, and a brief section 
outlining recommendations for future research. 
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CHAPTER TWO: LITERATURE REVIEW 
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2.1 Introduction 
This chapter discusses the review of literature related to prevalence of cancer in Malaysia, 
the common medical treatments that cancer patients undergo, the prevalence of CAM 
among healthy Malaysians as well as patients with chronic diseases including cancer, and 
the reasons for CAM use. In addition, cancer patients’ CAM disclosure to doctors and the 
impact of CAM therapies on cancer patients’ quality of life are discussed. 
2.2 Burden of cancer world wide 
Cancer is among the leading causes of death globally (World Health Organization, 2013). 
In 2008, 7.6 million people were reported to have died due to cancer; whereby an 
estimated 30% of the cancers were preventable. Deaths from cancer worldwide are 
expected to rise to over 13.1 million in 2030 (World Health Organization, 2013). Middle to 
low income countries reported higher incidence of cancer and approximately 70% of the 
deaths were reported from these countries. Lung (1.37 million deaths), stomach (736 000 
deaths), liver (695 000 deaths), colorectal (608 000 deaths), breast (458 000 deaths) and 
cervical cancer (275 000 deaths) are identified as the most common types of cancers 
worldwide. In the region of south-east Asia, the most common cancers are lung (14.7%) 
and breast (22.4%) cancers among men and women respectively (World Health 
Organization, 2008a).  
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2.3 Burden of cancer in Malaysia and treatment options available 
In Malaysia, during the recent years, diseases such as hypertension, ischemic heart disease, 
diabetes mellitus and cancer have largely replaced the diseases such as malaria, 
tuberculosis and infant gastrointestinal diseases (World Health Organization, 2013). 
Changes in lifestyle habits such as excessive smoking, alcohol consumption, and sexually 
transmitted diseases have also increased the incidence of cancers. In 2006, a total of 21,773 
cancer cases were diagnosed among Malaysians in Peninsular Malaysia and were 
registered in the National Cancer Registry (NCR). This included 9,974 males and 11,799 
females. Regardless of sex, the Age Standardized incidence Rate (ASR) for all cancers 
during the year 2006 was 131.3 per 100,000 (Malaysian Cancer Statistics, 2006). The five 
most common cancers identified were breast, colorectal, lung, cervix and nasopharynx. 
Estimated incidence and mortality due to the five most common cancers among 
Malaysians (both sexes) are summarized in Table 2.1. 
Table 2.1: Estimated incidence and mortality due to five most common cancers 
among Malaysians (both sexes) 
Cancer Incidence N (%) 
Mortality 
N (%) 
 
Breast 
Colorectum 
Lung 
Cervix-uteri 
Nasopharynx 
 
4485(14.0) 
3651(11.4) 
3628(11.3) 
2126(6.6) 
2000(6.3) 
 
1716(8.5) 
2356(11.7) 
3309(16.5) 
631(3.1) 
297(1.5) 
Source: Malaysian Cancer Statistics, 2006 
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The ASR among males and females were 128.6 per 100,000 and 135.7 per 100,000 
respectively. While looking at the ethnic variations, cancer seems to be more predominant 
among the Chinese as compared to those of Malay and Indian descent. The ASR for 
Chinese males and females was 148.0 per 100,000 and 151.5 per 100,000 respectively, 
while for Malay males and females it was 94.5 per 100,000 and 96.4 per 100,000 
respectively (Malaysian Cancer Statistics, 2006). This variation could be due to genetic 
differences as well as awareness towards reporting cancer symptoms to oncology 
professionals. Lack of awareness of the early signs of cancer and a fear of conventional 
treatments are among the reasons Malay cancer patients are reported to seek treatment 
from local traditional practitioners before seeking advice from oncology professionals 
(Lim, 2002). Furthermore, modern health care services in Malaysia rely largely on many 
traditional systems of treatment that reflect different groups and cultures. During the past 
few decades considerable attention has been given to traditional modes of healing, 
recognizing their role in the national health care system. Some of the common treatment 
methods available for Malaysian oncology patients are summarized in Figure 2.1.  
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Figure 2.1: Types of cancer treatments available in Malaysia  
Source: Malaysian Oncology Society, 2011 
 
Conventional therapies 
Cancer treatment is multidisciplinary and requires the skills of a team of experts. 
Conventional treatments are those that are widely used in the modern health care system. 
They are usually considered as Evidence Based Medicines (EBM) i.e. the safety and 
efficacy of these therapies have been well established through clinical trials. Professionals 
trained in this stream of treatment include oncologists, oncology nurses, radiation 
therapists, and oncology pharmacists. The conventional treatment offered by hospitals in 
Malaysia usually includes surgery, chemotherapy, radiotherapy, hormonal therapy and 
palliative care. The oncology services in government hospitals face a lack of experts and 
equipments. However; networking between government and private hospitals has helped in 
coping with the ever growing burden of cancer on the Malaysian health care system (Lim, 
2006). Surgical procedures and chemotherapy is usually provided in most of the 
government, district and private hospitals throughout the country. Simultaneously, 
radiotherapy services are provided by private radiology centres. In 2002, there were 14 
Cancer Treatment 
Conventional Therapies  
 
• Surgery 
• Radiotherapy 
• Chemotherapy 
• Targeted therapies 
• Immune therapies 
• Hormone therapies 
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radiology centres all over the country including two in government hospitals, three in 
universities and nine in the private sector (Lim, 2002). Currently a number of private 
oncology centres are emerging in the major cities where the facilities are comparable to 
developed countries. For example, in Penang state itself there are six private hospitals fully 
equipped with major cancer treatment services offering treatments to many patients from 
neighbouring countries, making Penang a hub for health tourism.  
The location of hospitals and the services provided has a major impact on patients’ 
behaviour in seeking cancer treatments. Considering the case of the northern region of 
Malaysia, the Penang General Hospital provides major oncology services for most types of 
cancers, while the hospital in Alor Star has expertise in gynaecological cancer and caters 
for most of such cases. With such collaborative care and mutual understanding, cancer 
patients from the northern region are receiving the best of cancer care. 
2.4 Use of Complementary and Alternative Medicines (CAM) among cancer 
patients 
 
The use of CAM for health and for healing purposes has long existed in human society. In 
the modern era, therapies which are now used to complement or as an alternative to 
conventional medicines, were the only way of cure in ancient times. However, a boost in 
modern drug delivery options excluded CAM. The basis of many of the modern treatments 
for cancer originated in pre-modern society and were used for treatment and prevention. 
For example, Vincristine (Oncovin®) was used as folk remedy for centuries until scientists 
revealed that this medicinal plant has a number of alkaloids, some of which are responsible 
for myelo-suppression (decreased activity of the bone marrow) (Costa-Lotufo et al., 2005). 
13 
 
In the modern era of the 21st century, many of the underdeveloped countries such as 
African and some of the south East Asian countries rely solely on CAM as a source of 
treatment (World Health Organization, 2008b). Lack of health care facilities, poverty and 
the disease burden on the health care system forced many patients to choose CAM as their 
first option for treatment. At the same time cultural influences and a lack of knowledge 
regarding modern therapies turns many cancer patients towards CAM. In this context 
defining CAM is a difficult task, as what is considered as CAM in one region of the world 
could be part of conventional treatment in other regions.  
2.5 CAM definition 
Defining CAM and ordering them into different categories is not an easy task. CAM is a 
broad field and CAM modalities are constantly increasing. ‘Complementary’ and 
‘alternative’ medicines are two distinct terms which have a great difference in meaning. 
‘Complementary’ can mean therapies which are used to complement conventional 
medicines. On the other hand ‘alternative’ treatments are something alternative to 
conventional therapies. However, within the literature on CAM there is a certain amount of 
ambiguity. The word CAM is simply used in most of the literature as therapies alternative 
to conventional medicines (Micke et al., 2009; Sewitch & Rajput, 2010). However, looking 
at the meaning of ‘complementary’ it could be therapies which are used to complement the 
conventional medicines. Eisenberg and colleagues in an attempt to evaluate the use of 
CAM amongst the US population, defined alternative or unconventional therapies as 
“medical treatments that are not widely used in US medical schools or generally available 
at US hospitals” (Eisenberg et al., 1993). Complementary medicine was originally defined 
by Ernst and colleagues as “ a diagnosis, treatment and/or prevention that complements 
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mainstream medicine by contributing to a common whole, by satisfying a demand not met 
by orthodoxy or by diversifying the conceptual frameworks of medicine” (Ernst et al., 
1995).  
In recent years significant emphasis has been given to defining CAM from a cultural 
context, since what is considered as CAM in European/Western cultures could be part of 
daily health care practice in other regions of the world (for e.g. acupuncture in North 
America vs China). A blended and more flexible definition of CAM has been given by 
Zollman and Vickers who define CAM as “a broad domain of healing resources that 
encompasses all health systems, modalities and practices, and their accompanied theories 
and beliefs other than those intrinsic to the politically dominated health system of a 
particular society or culture in a given historical period” (Zollman & Vicker, 1999). A 
similar definition is given by the WHO, where CAM is defined as “a broad set of health 
care practices that are not part of that country's own tradition and are not integrated into the 
dominant health care system” (World Health Organization, 2008b). Within this thesis, 
CAM is defined as “a group of diverse medical and healthcare systems, practices, and 
products that are not currently part of conventional medicines” (National Centre for 
Complementary and Alternative Medicines, 2011). Table 2.2 provides different types of 
CAM therapies classified by the US National Centre for Complementary and Alternative 
Medicines (NCCAM). 
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Table 2.2: US National Centre for Complementary and Alternative Medicine 
(NCCAM) classification of the major types of CAM 
 
CAM CATEGORIES EXAMPLES 
Biologically Based Therapies which use 
substances found in nature to promote health. 
Nutritional supplements (vitamins, 
mineral, enzymes) 
Special diet(herbs, animal products, juices) 
Mind Body Complementary Therapies 
which uses a variety of techniques to enhance 
the mind's capacity to affect bodily function 
and symptoms. 
Prayers for health reasons/spirituality 
Others (meditation, T’ai chi, music, yoga, 
Qigong, hypnotherapy, Reiki) 
Whole Medical System which are complete 
systems of theory and practice outside the 
conventional allopathic model 
Traditional Chinese medicines 
Homeopathy 
Ayurveda 
Energy Medicines which involves the use of 
energy fields, either the unconventional use 
of electromagetic fields, or the manipulation 
of energy fields that purportedly surround 
and penetrate the human body. 
Light therapy, Ozone therapy 
Manipulative Body Based Therapies which 
are based on manipulation and/ or movement 
of parts of the body. 
Massage, herbal baths/aromatherapy 
Source: National Centre for Complementary and Alternative Medicines, 2011 
2.6 Complementary and Alternative Medicines (CAM) in Malaysia 
Malaysian society represents a refine amalgamation of multiple races and cultures which 
offers a wide range of traditional methods of healing. Understanding the roots of the 
Malaysia’s historical background and the health care system may help to understand CAM 
use among Malaysian cancer patients. Before independence the local people were reported 
to have their health beliefs and practices which reflect the medical traditions of the Arab, 
the Hindus and various other people who were settled in the Malay Peninsula at that time 
(Chee & Barraclough, 2007). A large migration of Chinese and Indian labourers brought 
with them their healers and healing medicines. Simultaneously, Malaysia’s rich tropical 
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biodiversity is a reliable source of natural products. In general, diverse culture with 
different ethnic races and the unique flora and fauna makes Malaysia as a platform for 
several kinds of traditional medicines.  
The current health care system in Malaysia is based on western medicine which is 
dominant politically and culturally. A growing interest in traditional modes of healing 
globally has encouraged many countries to recognize the importance of traditional 
medicines in their primary health care systems (World Health Organization, 2008b). The 
WHO, through its traditional medicines program has encouraged countries to recognize the 
preventive and curative aspects of traditional medicines in the nation’s health care system 
(World Health Organization, 2008b).  
The main objectives of WHO traditional medicines program are: 
i. To facilitate the integration of traditional medicine into national health care systems  
ii. To promote the rational use of traditional medicine through the development of 
technical guidelines and standards. 
iii. To disseminate information on various forms of traditional medicines   
iv. To ensure patient safety by upgrading the skills and knowledge of traditional 
medicine providers. 
Based on the above objectives, Malaysia established policy on CAM in 1999, with the aim 
to integrate CAM into the Malaysian health care system to achieve a holistic approach 
towards enhancing health and the quality of life (National policy on 
traditional/complementary medicine, 2001). The Traditional and Complementary 
Medicines (T/CM) division was established under the ministry of health Malaysia which 
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aims to promote proper use of CAM, provision of appropriate education and training to 
CAM practitioners as well as the establishment of strong research activities in CAM 
development. Malaysian policy on CAM defines CAM as “Traditional and 
Complementary Medicine (T/CM) practice together is other than practice of medicine or 
surgery by registered medical practitioners, as defined in Medical Act 1971, (Malaysia)” 
(National policy on traditional/complementary medicine, 2001). Table 2.3 provides 
different types of CAM practices offered by traditional and complementary medicines unit, 
ministry of health, Malaysia for patients with different chronic diseases such as stroke and 
cancer (Portal Rasmi Bahagian Perubatan Tradisional & Komplementari, 2011).  
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Table 2.3: Common CAM practices in Malaysia  
CAM practices Examples 
 
Traditional Malay Medicine (TMM) Malay herbs, Malay massage, Bekam (Cupping) 
Traditional Chinese Medicines 
(TCM) 
Acupuncture & Moxibustion, Chinese herbs, 
Tuina, Qigong 
Traditional Indian medicines (TIM) Ayurveda, Siddha, Unani, Yoga 
Homeopathy Medicines  A system for treating disease based on the 
administration of minute doses of a drug that in 
massive amounts produces symptoms in healthy 
individuals similar to those of the disease itself.  
Complementary Medicines Manipulative based therapies (Chiropractor, 
osteopathy, therapeutic massage, spa therapy, 
reflexogy, Thai massage, Swedish massage, 
Balinese/Javanese massage, Shiatsu massage, and 
aromatherapy. 
Energy medicine (colour vibration therapy, 
crystal healing, reiki, aura metaphysics, roaha, 
bach flower, phytophysics) 
Mind body soul therapy (hypnotherapy, 
psychotherapy) 
Biological based practices (nutritional therapy, 
naturopathy) 
Islamic Medicine Practices The effort at seeking treatment for physical and 
spiritual ailments; done by a Muslim who is 
knowledgeable and skilled in treatment methods 
using Quranic verses, Hadith, the practices of the 
pious and righteous scholars, and of the venerated 
religious teacher; and also skilled with the use of 
methods or materials are permitted by the Islamic 
law. 
Source: Portal Rasmi Bahagian Perubatan Tradisional & Komplementari, 2011 
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2.7 Prevalence of CAM use among cancer patients 
In general CAM use is common among healthy individuals as well as patients with chronic 
diseases such as arthritis, HIV/AIDS and cardiovascular diseases (Callahan et al., 2009; 
Dhalla et al., 2006; Yeh, Davis, & Phillips, 2006). On average 40% of cancer patients from 
western societies including Australia, Canada, Europe, New Zealand and the USA use 
CAM (Horneber et al., 2012). In the US, a population based survey reported that 40% of 
cancer survivors had used CAM during the previous year (Mao et al., 2007). In a systemic 
review of 52 studies including 14 countries from western and eastern regions showed that 
the prevalence of CAM use ranged from as low as 5% to as high as 60% with an average 
prevalence of 31.4% in adult cancer patients (Verhoef et al., 2005).   
Very few studies reported that the prevalence of CAM use among Asian cancer patients 
which is relatively higher than that of Western countries (Ben-Arye et al., 2012). For 
example, among the Asian cancer population the reported CAM prevalence is, China 
(93.4%), Sri Lanka (67.4%),  Malaysia (64%), Thailand (60.9%),  Singapore (56%), 
Pakistan (54.5%), Turkey (42.3%)  and in India (34.3%) (Liu et al., 2012; Broom et al, 
2010; Shaharudin et al., 2011; Puataweepong, Sutheechet, & Ratanamongkol, 2012; Shih, 
Chiang, & Chan, 2009; Malik, Khan, & Khan, 2000; Tarhan et al., 2009; Broom et al., 
2009). The wide variation in the frequency of CAM use shown within these studies could 
be due to understandings of CAM, the list of CAM therapies provided during interviews 
(predefined list of CAM given vs. recall of CAM without being prompted), frequency of 
CAM use and restrictions to consider only certain CAM therapies as a study’s objective.  
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The understanding of the concept of CAM may vary the pattern of response. Different 
people consider CAM in different ways, for example, prayers and spiritual therapies are 
perceived as a daily life practice for some patients and thus not reported as CAM but for 
others it can be considered as CAM (Elizabeth Johnston, 2005).  
It is also noticeable that the duration of CAM use may also affect the percentage reported. 
Surveys investigating CAM use since cancer diagnosis may have a high CAM prevalence 
compared to surveys investigating CAM use within a limited duration (for example, the 
last six months or a year). Similarly one may also argue that face to face interviews may 
introduce some bias when eliciting responses, especially if the survey is conducted in a 
conventional oncology setting or the interviewer is a nurse or pharmacist from the same 
setting thus forcing patients to respond positively in a socially desirable manner. Since fear 
of termination of therapy is reported among the reasons for CAM non-disclosure this 
debate could be acceptable to some extent (Robinson &McGrail, 2004). 
2.8 The CAM use decision making process 
The decision to use CAM is a highly complex process which revolves around many issues.  
A simplified model of the CAM decision making process is given in Figure 2.2.  
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Figure 2.2: Summary of CAM decision making process 
An individual’s perspective towards health and disease may affect the treatment decision. 
Factors affecting CAM use are diverse and are not merely due to a dissatisfaction with 
conventional medicines but more as an alternative to avoid cancer recurrence, to strengthen 
the body after or during cancer treatment and for psychological well being (Gerber et al., 
2006). Mao and colleagues while investigating CAM users’ unmet need, found out that 
emotional, physical, nutritional, financial, treatment related information and employment 
factors were the common unmet needs among 50% of cancer patients (Mao et al., 2008). A 
similar review concluded that the CAM use was associated with a strong belief in CAM, a 
need for control and considering CAM as a last resort and hope for cure (Verhoef et al., 
2005).  
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The emotional impact of cancer diagnosis, perceptions of the disease, the availability of 
different treatment options and the cost of therapy may act as pulling or pushing factors in 
CAM use (Verhoef & White, 2002). Patients with a passive behaviour towards treatment 
may rely on their physician’s advice. However, patients actively participating in the 
treatment decision may contribute to the CAM decision making process.  
The first phase in the CAM decision making process involves gathering information about 
CAM. Due to the availability of a wide range of CAM, patients usually find themselves 
with a pool of CAM therapies where choosing one or picking the best one is always a 
challenging task (Boon et al., 1999). Recommendations from friends and family members 
and other cancer survivors are some of the sources reported to help patients in CAM 
selection (Hirai et al., 2008; Hyodo et al., 2005). Patient judgment to the potential risks and 
benefits of CAM and the possible interactions with conventional medicines may also affect 
CAM decision (Verhoef & White, 2002).  
The cost and availability of CAM may also affect the decision to use CAM (Balneaves et 
al., 2006; Gupta et al., 2002). Although low cost and easy access are among the reasons 
given for CAM use this is not true in all cases (Ezeome & Anarado, 2007). Homemade 
traditional therapies may provide patients with easy and cheap access to these therapies, 
but most of the commercial products including mega vitamins, herbal drinks and 
supplements are relatively expensive. Traditional Chinese Medicines (TCM) are easily 
available in China but may not be so easily available for patients from other parts of the 
world. Travelling or shipment cost may also affect a patient’s decision to use CAM. 
Diagnosis with cancer may also affect a patient’s productivity (job loss) or the cost of 
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conventional treatment may be a burden (Choi et al., 2007). In such situations the extra 
cost of CAM therapies may affect patient decisions regarding using CAM. Thus beside 
affordability, the availability of certain CAM may affect the CAM decision making 
process (Bodeker & Kronenberg, 2002). 
Ascertaining the appropriate phase of cancer to start a CAM in order to avoid interaction 
with conventional therapies is another aspect which affects the decision of CAM use (Shen 
et al., 2002). Using one CAM at a time to avoid CAM-CAM interactions as well as to 
evaluate the effectiveness of a certain CAM could also be an important factor in CAM 
decisions. Similarly patient decisions to use non-invasive CAM therapies while undergoing 
conventional treatment may also affect the choice of CAM modalities. Therapies like 
massage, relaxation techniques, yoga, Qigong, and music therapies have been commonly 
used by cancer patients to meet those psychological needs which are not fully supported by 
conventional therapies (Deng & Cassileth, 2005). Patients were also reported to revisit 
their decision to use CAM after the end of conventional treatment in order to regain 
strength and energy after going through chemotherapy or radiotherapy (Balneaves, Weeks, 
& Seely, 2008). At the same time, fear of cancer recurrence or metastasis may also force 
patients to revisit their CAM decision and to try therapies which they rejected during the 
initial phase (Henderson & Donatelle, 2004).  
In summary the CAM decision making process is highly individualized, complicated and 
revolves around multiple factors. Patients’ values, beliefs, knowledge and specific health 
care needs may affect this highly complex process. 
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2.9 Theoretical explanations for CAM use 
2.9.1 The health belief model and its connectivity with CAM use  
Several health behaviour models have been proposed to understand an individual’s health-
related behaviour. The best known model in public health is the Health Belief Model 
(HBM) which was introduced to understand human behaviour towards seeking health 
services such as immunization and screening (Becker, 1974). The model’s four key 
components are conceptualized as; perceived susceptibility, perceived severity, perceived 
benefits, and perceived barriers. The model assumes that an individual’s health behaviour 
depends upon beliefs regarding the impact of the illness and its consequences, provided 
that the individual has a distinct course of action by which to proceed.  
Although few studies have utilized HBM in understating cancer patients’ CAM use, some 
of its constructs well apply to identifying reasons why people choose to use CAM. 
Perceived severity of illness may contribute to CAM use. Patients with poor knowledge 
regarding cancer and its treatment and the perceived severity of untreated cancer may 
delay the process of seeking proven therapies while searching for CAM. Perceived 
susceptibility of getting cancer may also contribute to using CAM to prevent cancer 
occurrence. Similarly, perceived susceptibility to cancer recurrence is also linked to CAM 
use among cancer survivors (Henderson & Donatelle, 2004). Perceived benefits of both 
conventional and CAM therapies may affect a decision to use CAM (Boon et al., 2000). 
On the other hand perceived severity of the side effects caused by conventional therapies is 
given as reason for CAM use (Verhoef & White, 2002). In certain cases CAM is perceived 
